tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Design Therapeutics sees cash runway into 2029

Cash, cash equivalents and marketable securities were $245.5M as of December 31, 2024, which the company expects to fund its planned operating expenses into 2029.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1